AAAAAA

   
Results: 1-8 |
Results: 8
CD34(+) immunoselected cells for poor graft function following allogeneic BMT
Authors: Mohty, M Faucher, C Chabannon, C Vey, N Stoppa, AM Ladaique, P Novakovitch, G Olivero, S Bouabdallah, R Gastaut, JA Maraninchi, D Blaise, D
Citation: M. Mohty et al., CD34(+) immunoselected cells for poor graft function following allogeneic BMT, CYTOTHERAPY, 2(5), 2000, pp. 367-370
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation
Authors: Mohty, M Faucher, C Vey, N Stoppa, AM Viret, F Chabbert, I Chabannon, C Bouabdallah, R Ladaique, P Collet, L Zandotti, C Maraninchi, D Baise, D
Citation: M. Mohty et al., High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation, BONE MAR TR, 26(3), 2000, pp. 251-255
T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselectionof CD34(+) cells
Authors: Olivero, S Novakovitch, G Ladaique, P Sainty, D Viret, F Faucher, C Stoppa, AM Blaise, D Chabannon, C
Citation: S. Olivero et al., T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselectionof CD34(+) cells, CYTOTHERAPY, 1(6), 1999, pp. 469-477
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement
Authors: Viret, F Blaise, D Bouabdallah, R Stoppa, AM Novakovitch, G Faucher, C Vey, N Camerlo, J Oziel-Taieb, S Ladaique, P Gastaut, JA Maraninchi, D Chabannon, C
Citation: F. Viret et al., Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement, HEM CELL TH, 41(1), 1999, pp. 5-11
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients
Authors: Bouabdallah, R Stoppa, AM Rossi, JF Lepeu, G Coso, D Xerri, L Ladaique, P Chabannon, C Blaise, D Bardou, VJ Alzieu, C Gastaut, JA Maraninchi, D
Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956
Transplantation of allogeneic CD34(+) blood cells in leukemia or lymphoma patients at high risk of GVHD
Authors: Viret, F Chabannon, C Aurran-Schleinitz, T Reviron, D Stoppa, AM Faucher, C Ladaique, P Gastaut, JA Maraninchi, D Blaise, D
Citation: F. Viret et al., Transplantation of allogeneic CD34(+) blood cells in leukemia or lymphoma patients at high risk of GVHD, BONE MAR TR, 24(2), 1999, pp. 225-227
CD34(+) cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol
Authors: Olivero, S Alario, T Ladaique, P Haccoun, M Viens, P Blaise, D Chabannon, C
Citation: S. Olivero et al., CD34(+) cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol, BONE MAR TR, 23(4), 1999, pp. 387-394
Optimization of peripheral blood stem cell collection by leukopheresis - Interaction between economic and clinical assessment of an innovation
Authors: Le Corroller, AG Moatti, JP Chabannon, C Faucher, C Fortanier, C Ladaique, P Blache, JL Novakovitch, G Maraninchi, D Blaise, D
Citation: Ag. Le Corroller et al., Optimization of peripheral blood stem cell collection by leukopheresis - Interaction between economic and clinical assessment of an innovation, INT J TE A, 15(1), 1999, pp. 161-172
Risultati: 1-8 |